Found 8 matching trials
Follow Up of Patients Chronic Hepatitis B (CHB) Treated With Sebivo Using the 13C Methacetin Breath Test
PHASE2Patients with HBeAg negative chronic HBV and evidence of hepatic disease (e...
Location
Liver Unit, Hadassah Hebrew University Medical Center
13C-Methacetin Breath Test for the Prediction of Outcome in in ALI or ALF
PHASE2The ALFSG-MBT protocol is for a multicenter, open label, non-randomized stu...
Location
University of Alabama, Birmingham
Prediction Value of the BreathID 13C-Methacetin Breath Test for Hepatic Decompensation
N/AThe objectives of this study are:
* To evaluate the ability of the Methace...
Location
Henry Ford Health System
Companion Protocol for ¹³C-Methacetin Breath Tests in BMS: NCT03486899, NCT03486912 Referenced Trials
N/AThis is a companion study assessing the ¹³C-Methacetin Breath Test (MBT) in...
Location
Spring Gastroenterology
BreathID 13C-Methacetin Breath Test for Detecting Cirrhosis
PHASE3This trial is a pivotal trial to validate the use of a 13 C labeled substra...
Location
Cedars Sinai Medical Center
BREATHID Octanoate Breath Test With or Without Methacetin Breath Test for Correlation With Biopsy in NASH
PHASE2This study's aim is to develop an algorithm for the ¹³C-Octanoate Breath Te...
Location
Northwestern University, Feinberg School of Medicine
Use of Methacetin Breath Test to Predict Liver Failure in Patients With Cirrhosis
PHASE3The methacetin breath test (MBT) is a non-invasive liver function test whic...
Location
Henry Ford Health System
Assessing Portal Hypertension With Methacetin Breath Test
NAThis study will be used to train an algorithm using Methacetin breath test ...
Location
VA Connecticut HealthCare System